Hennes, E., Baumann, M., Schanda, K., Anlar, B., Bajer-Kornek, B., Blaschek, A., Brantner-Inthaler, S., Diepold, K., Eisenkölbl, A., Gotwald, T., Kuchukhidze, G., Gruber-Sedlmayr, U., Häusler, M., Höftberger, R., Karenfort, M., Klein, A., Koch, J., Kraus, V., Lechner, C., Leiz, S., Leypoldt, F., Mader, S., Marquard, K., Poggenburg, I., Pohl, D., Pritsch, M., Raucherzauner, M., Schimmel, M., Thiels, C., Tibussek, D., Vieker, S., Zeches, C., Berger, T., Reindl, M., & Rostásy, K. (2017). prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology, 89, . http://access.bl.uk/ark:/81055/vdc_100070745968.0x00002e